MNPR Competitors & Alternatives
Compare Monopar Therapeutics Inc with similar stocks in the same industry
Biotechnology
MNPR
Main Stock$72.68
Tradestie Score
46
Market Cap
$522.78M
Analyst Upside
+78.8%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.82
|
$512.39M | - | 38 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$45.69
|
$505.12M | 2.7 | 59 | Compare |
|
RGNX
REGENXBIO Inc.
|
$8.03
|
$493.52M | - | 32 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$87.75
|
$492.21M | - | 39 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.14
|
$468.01M | - | 43 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$9.31
|
$463.20M | - | 37 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.00
|
$457.09M | - | 35 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.68
|
$454.29M | - | 44 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
More MNPR Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry